Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


12.08.2024

1 Acta Cytol
1 Adv Sci (Weinh)
1 Afr J Prim Health Care Fam Med
1 Afr J Reprod Health
1 Am J Cancer Res
1 Anticancer Drugs
3 Aust N Z J Obstet Gynaecol
1 Biotechnol Appl Biochem
2 BMC Public Health
1 Br J Health Psychol
1 Cancer
2 Cancer Med
1 Carcinogenesis
1 Cell Death Dis
1 Chin Med J (Engl)
1 Curr Med Res Opin
1 Curr Opin Oncol
1 Cytopathology
1 Dis Colon Rectum
1 Ethn Health
1 Eur J Nucl Med Mol Imaging
2 Eur J Surg Oncol
1 Front Mol Biosci
1 Front Oncol
1 Front Public Health
1 Gynecol Obstet Invest
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 Health Expect
1 HLA
1 IEEE/ACM Trans Comput Biol Bioinform
1 Infect Dis Obstet Gynecol
1 Int Immunopharmacol
4 Int J Gynecol Cancer
1 Int J Med Sci
1 Int J Radiat Biol
1 J Adolesc Young Adult Oncol
1 J Appl Clin Med Phys
1 J Clin Oncol
1 J Immunother Cancer
1 J Low Genit Tract Dis
1 JCO Glob Oncol
1 Lakartidningen
2 Lancet
1 Luminescence
2 Magn Reson Imaging
1 Med Oncol
1 Medicine (Baltimore)
1 Methods
1 Natl Med J India
1 Nurs Womens Health
1 Oncol Lett
1 Phys Eng Sci Med
2 PLoS One
1 S Afr Fam Pract (2004)
2 Sci Rep
1 Small
1 Strahlenther Onkol
1 Talanta
1 Value Health
1 Virol J
1 Zhongguo Zhong Yao Za Zhi
1 Zhonghua Bing Li Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Cytol

  1. VRDOLJAK-MOZETIC D, Stemberger-Papic S, Versa Ostojic D, Rubesa R, et al
    Pitfalls in Gynecological Cytology: Review of the Common and Less Frequent Entities in Pap Test.
    Acta Cytol. 2024;68:281-298.
    PubMed         Abstract available


    Adv Sci (Weinh)

  2. QIAO R, Yuan Z, Yang M, Tang Z, et al
    Selenium-Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization.
    Adv Sci (Weinh). 2024;11:e2402039.
    PubMed         Abstract available


    Afr J Prim Health Care Fam Med

  3. NGAMBI D, Ramathuba DU
    Challenges regarding the implementation of cervical cancer screening guidelines in Limpopo province, South Africa.
    Afr J Prim Health Care Fam Med. 2024;16:e1-e7.
    PubMed         Abstract available


    Afr J Reprod Health

  4. MOKWENA BP, Gundo R, Mulaudzi FM
    Factors that influence the uptake of human papillomavirus vaccine among preadolescent girls in South Africa: A Scoping Review.
    Afr J Reprod Health. 2024;28:127-148.
    PubMed         Abstract available


    Am J Cancer Res

  5. REGINACOVA K, Pospisilova E, Kubecova M, Svobodova P, et al
    Circulating tumor cells in patients with cervical cancer undergoing chemoradiotherapy combined with brachytherapy.
    Am J Cancer Res. 2024;14:3614-3625.
    PubMed         Abstract available


    Anticancer Drugs

  6. YONG X, Zhang Y, Tang H, Hu H, et al
    CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma.
    Anticancer Drugs. 2024;35:698-708.
    PubMed         Abstract available


    Aust N Z J Obstet Gynaecol

  7. DEANS R, Moses D, Sach TA, Vancaillie T, et al
    Perfusion magnetic resonance imaging in Asherman syndrome.
    Aust N Z J Obstet Gynaecol. 2024;64:341-346.
    PubMed         Abstract available

  8. ORMANDY J, Phillips S, Campbell M, Haenga-Melvin B, et al
    'I was able to make a better decision about my health.' Wahine experiences of colposcopy at a marae-based health clinic: A qualitative study.
    Aust N Z J Obstet Gynaecol. 2024;64:368-374.
    PubMed         Abstract available

  9. TAN JHJ, Neesham D, Szabo RA, Khomko N, et al
    Colposcopy performance in the new primary HPV screening in Australia: How to determine colposcopy competency?
    Aust N Z J Obstet Gynaecol. 2024;64:375-382.
    PubMed         Abstract available


    Biotechnol Appl Biochem

  10. KANG C, Qiu L, Duo Y, Bi F, et al
    HPV18 E6/E7 activates Ca(2+) influx to promote the malignant progression of cervical cancer by inhibiting Ca(2+) binding protein 1 expression.
    Biotechnol Appl Biochem. 2024 Aug 7. doi: 10.1002/bab.2650.
    PubMed         Abstract available


    BMC Public Health

  11. MORSE RM, Brown J, Rios Lopez EJ, Prieto BA, et al
    Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention.
    BMC Public Health. 2024;24:2121.
    PubMed         Abstract available

  12. COURSEY K, Muralidhar K, Srinivas V, Jaykrishna P, et al
    Acceptability of HPV vaccination for cervical cancer prevention amongst emerging adult women in rural Mysore, India: a mixed-methods study.
    BMC Public Health. 2024;24:2139.
    PubMed         Abstract available


    Br J Health Psychol

  13. POLUEKTOVA O, Robertson DA, Papadopoulos A, Lunn PD, et al
    Trust in cervical screening and attributions of blame for interval cancers following a national controversy.
    Br J Health Psychol. 2024;29:788-813.
    PubMed         Abstract available


    Cancer

  14. ISSAKA RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, et al
    Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
    Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514.
    PubMed         Abstract available


    Cancer Med

  15. LIU FY, Chen WC, Pan YB, Wang CC, et al
    Clinical factor-based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix.
    Cancer Med. 2024;13:e6746.
    PubMed         Abstract available

  16. YU H, Lin Y, Lin J, Xie N, et al
    Causes of death analysis and the prognostic model construction in neuroendocrine carcinoma of the cervix: A SEER-based study.
    Cancer Med. 2024;13:e70066.
    PubMed         Abstract available


    Carcinogenesis

  17. SUN Y, Peng Q, Wang R, Yin Y, et al
    Elevated expression of Golgi Transport 1B promotes the progression of cervical cancer by activating NF-kappaB signaling pathway via interaction with TBK1.
    Carcinogenesis. 2024 Aug 8:bgae054. doi: 10.1093.
    PubMed         Abstract available


    Cell Death Dis

  18. WANG S, Qiao X, Cui Y, Liu L, et al
    NCAPH, ubiquitinated by TRIM21, promotes cell proliferation by inhibiting autophagy of cervical cancer through AKT/mTOR dependent signaling.
    Cell Death Dis. 2024;15:565.
    PubMed         Abstract available


    Chin Med J (Engl)

  19. WANG Y, Song W, Wang H, Zhu G, et al
    Increased risk of subsequent primary lung cancer among female hormone-related cancer patients: A meta-analysis based on over four million cases.
    Chin Med J (Engl). 2024;137:1790-1801.
    PubMed         Abstract available


    Curr Med Res Opin

  20. DEVNATH R, Sharma K
    Government's bold initiatives: tackling cervical cancer in India with determination and commitment.
    Curr Med Res Opin. 2024 Aug 5:1-4. doi: 10.1080/03007995.2024.2388221.
    PubMed        


    Curr Opin Oncol

  21. LAUFER J, Scasso S, Papadia A
    Different tracers for sentinel node detection in gynecologic oncology.
    Curr Opin Oncol. 2024;36:371-375.
    PubMed         Abstract available


    Cytopathology

  22. KOYANAGI T, Fujiwara H, Yamamoto K, Suzuki M, et al
    Cervical cancer screening efficacy using SurePath, ThinPrep and conventional cytology: A large data set analysis from the Japan Cancer Society.
    Cytopathology. 2024 Aug 8. doi: 10.1111/cyt.13431.
    PubMed         Abstract available


    Dis Colon Rectum

  23. WANG A, Zhang P, Bian C, Chen M, et al
    Laparoscopic Total Mesorectal Excision With Combined Resection of the Ureter and Ureterovesical Reimplantation for Recurrent Cervical Adenocarcinoma.
    Dis Colon Rectum. 2024;67:e1540-e1541.
    PubMed        


    Ethn Health

  24. SARMIENTO-MEDINA MI, Velasquez-Jimenez CM, Ortiz-Hernandez N
    Experiences of a group of indigenous women from the Colombian Amazon with cervical cancer prevention screening. Qualitative study in the context of participatory research to reduce inequalities.
    Ethn Health. 2024 Aug 6:1-15. doi: 10.1080/13557858.2024.2387112.
    PubMed         Abstract available


    Eur J Nucl Med Mol Imaging

  25. VAN OOSTEROM MN, Diaz-Feijoo B, Santisteban MI, Sanchez-Izquierdo N, et al
    Steerable DROP-IN radioguidance during minimal-invasive non-robotic cervical and endometrial sentinel lymph node surgery.
    Eur J Nucl Med Mol Imaging. 2024;51:3089-3097.
    PubMed         Abstract available


    Eur J Surg Oncol

  26. BERNARD L, Pond GR, Elit L, Vicus D, et al
    Safety of vaginal surgery for early-stage cervical cancer: A retrospective multicenter cohort study.
    Eur J Surg Oncol. 2024;50:108518.
    PubMed         Abstract available

  27. ZHANG Y, Zou J, Li L, Han M, et al
    Comprehensive assessment of postoperative recurrence and survival in patients with cervical cancer.
    Eur J Surg Oncol. 2024;50:108583.
    PubMed         Abstract available


    Front Mol Biosci

  28. HUANG X, Liu W, Liu C, Hu J, et al
    Corrigendum: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study.
    Front Mol Biosci. 2024;11:1452740.
    PubMed         Abstract available


    Front Oncol

  29. ALOHALI MA, El-Rashidy N, Alaklabi S, Elmannai H, et al
    Swin-GA-RF: genetic algorithm-based Swin Transformer and random forest for enhancing cervical cancer classification.
    Front Oncol. 2024;14:1392301.
    PubMed         Abstract available


    Front Public Health

  30. QIN L, Li D, Wang Z, Lan J, et al
    Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens.
    Front Public Health. 2024;12:1421774.
    PubMed         Abstract available


    Gynecol Obstet Invest

  31. DOMINONI M, Barcellini A, Pasquali MF, De Silvestri A, et al
    The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment.
    Gynecol Obstet Invest. 2024;89:295-303.
    PubMed         Abstract available


    Gynecol Oncol

  32. ADOLPH L, Mann A, Liu XQ, Roberts L, et al
    Follow-up of women with cervical adenocarcinoma in situ treated by conization: A single centre clinical experience.
    Gynecol Oncol. 2024;187:74-79.
    PubMed         Abstract available


    Gynecol Oncol Rep

  33. REZA S, Anjum R, Khandoker RZ, Khan SR, et al
    Public health concern-driven insights and response of low- and middle-income nations to the World health Organization call for cervical cancer risk eradication.
    Gynecol Oncol Rep. 2024;54:101460.
    PubMed         Abstract available


    Health Expect

  34. MACHADO COLLING A, Creagh NS, Gogia N, Wyatt K, et al
    The acceptability of, and informational needs related to, self-collection cervical screening among women of Indian descent living in Victoria, Australia: A qualitative study.
    Health Expect. 2024;27:e13961.
    PubMed         Abstract available


    HLA

  35. EISENBLATTER R, Seifert F, Schurmann P, Beckhaus T, et al
    Validation and functional follow-up of cervical cancer risk variants at the HLA locus.
    HLA. 2024;104:e15597.
    PubMed         Abstract available


    IEEE/ACM Trans Comput Biol Bioinform

  36. CHEN T, Zheng W, Hu H, Luo C, et al
    A Corresponding Region Fusion Framework for Multi-Modal Cervical Lesion Detection.
    IEEE/ACM Trans Comput Biol Bioinform. 2024;21:959-970.
    PubMed         Abstract available


    Infect Dis Obstet Gynecol

  37. BRAUTIGAM K, Meier S, Koster F, Rody A, et al
    CER818: A Highly Specific and Sensitive HPV L1 High-Risk Serological Lateral Flow Rapid Test for Early Detection of Cervical Cancer and Its Precursor Lesions.
    Infect Dis Obstet Gynecol. 2024;2024:6651272.
    PubMed         Abstract available


    Int Immunopharmacol

  38. GNANAGURUSAMY J, Krishnamoorthy S, Muthusami S
    Transforming growth factor-beta micro-environment mediated immune cell functions in cervical cancer.
    Int Immunopharmacol. 2024;140:112837.
    PubMed         Abstract available


    Int J Gynecol Cancer

  39. PEREZ VILLENA JF, Sanchez Salcedo M, Montoya Guivin A, Villoslada Terrones V, et al
    First workshop on cervix cancer surgery in Latin America: a hands-on experience from Lima, Peru.
    Int J Gynecol Cancer. 2024;34:1294-1295.
    PubMed        

  40. MATSUO K, Shimada M, Matsuzaki S, Machida H, et al
    Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2024 Aug 6:ijgc-2024-005597. doi: 10.1136/ijgc-2024-005597
    PubMed         Abstract available

  41. CARUSO G, Wagar MK, Hsu HC, Hoegl J, et al
    Cervical cancer: a new era.
    Int J Gynecol Cancer. 2024 Aug 7:ijgc-2024-005579. doi: 10.1136/ijgc-2024-005579
    PubMed         Abstract available

  42. ZAMBRANO HARVEY AR, Galvis-Catano LM, Bonilla-Escobar FJ, Zapata Izquierdo MA, et al
    Intercultural dialogues and multilevel strategies for cervical cancer prevention for the Arhuacos indigenous community in Colombia.
    Int J Gynecol Cancer. 2024 Aug 7:ijgc-2024-005871. doi: 10.1136/ijgc-2024-005871
    PubMed        


    Int J Med Sci

  43. DENG B, Kong W, Han C, Zhou C, et al
    Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients.
    Int J Med Sci. 2024;21:2000-2010.
    PubMed         Abstract available


    Int J Radiat Biol

  44. LIU T, Xie Q, Wang W
    Ultrasound-stimulated microbubbles enhances radiosensitivity in cervical cancer.
    Int J Radiat Biol. 2024 Aug 5:1-10. doi: 10.1080/09553002.2024.2374903.
    PubMed         Abstract available


    J Adolesc Young Adult Oncol

  45. CETIN SA, Cinar D
    Determination of Opinions on HPV Infection and HPV Vaccine among Nursing Students by Focus Group Discussion.
    J Adolesc Young Adult Oncol. 2024;13:693-702.
    PubMed         Abstract available


    J Appl Clin Med Phys

  46. XIAO H, Han Q, Wei S, Du M, et al
    Setup errors analysis in iterative kV CBCT: A clinical study of cervical cancer treated with Volumetric Modulated Arc Therapy.
    J Appl Clin Med Phys. 2024 Aug 9:e14480. doi: 10.1002/acm2.14480.
    PubMed         Abstract available


    J Clin Oncol

  47. BERCOW A, Del Carmen MG, Rauh-Hain JA, Melamed A, et al
    Role of Minimally Invasive Techniques in the Management of Early-Stage Carcinoma of the Uterine Cervix.
    J Clin Oncol. 2024;42:2731-2735.
    PubMed         Abstract available


    J Immunother Cancer

  48. WANG Z, Wang B, Feng Y, Ye J, et al
    Targeting tumor-associated macrophage-derived CD74 improves efficacy of neoadjuvant chemotherapy in combination with PD-1 blockade for cervical cancer.
    J Immunother Cancer. 2024;12:e009024.
    PubMed         Abstract available


    J Low Genit Tract Dis

  49. RAMASWAMY M, Hall B, Cejtin H, Sufrin C, et al
    Cervical Cancer Prevention in Individuals With Criminal Legal System Involvement.
    J Low Genit Tract Dis. 2024 Aug 7. doi: 10.1097/LGT.0000000000000833.
    PubMed         Abstract available


    JCO Glob Oncol

  50. FUADY A, Setiawan D, Man I, de Kok IMCM, et al
    Toward a Framework to Assess the Financial and Economic Burden of Cervical Cancer in Low- and Middle-Income Countries: A Systematic Review.
    JCO Glob Oncol. 2024;10:e2400066.
    PubMed         Abstract available


    Lakartidningen

  51. DILLNER J
    [Human papillomavirus type 18 - In memoriam].
    Lakartidningen. 2024;121:24055.
    PubMed         Abstract available


    Lancet

  52. SCHIFFMAN M, de Sanjose S
    The rational design of cervical cancer prevention strategies.
    Lancet. 2024;404:406-407.
    PubMed        

  53. WEI F, Georges D, Man I, Baussano I, et al
    Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature.
    Lancet. 2024;404:435-444.
    PubMed         Abstract available


    Luminescence

  54. CHITRA K, Sureshkumar M, Muraleedharan A, Selvamaleeswaran P, et al
    In vitro cancer cell line luminescence-based validation of anticancer phytocompounds obtained from Leucas biflora against HELA cervical and A549 lung cancer cells.
    Luminescence. 2024;39:e4855.
    PubMed         Abstract available


    Magn Reson Imaging

  55. LAI B, Yi Y, Yang X, Li X, et al
    Dynamic contrast-enhanced and diffusion-weighted MRI of cervical carcinoma: Correlations with Ki-67 proliferation status.
    Magn Reson Imaging. 2024 Jul 17:S0730-725X(24)00185.
    PubMed         Abstract available

  56. XIAO ML, Fu L, Ma FH, Li YA, et al
    Comparison of MRI features among squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma, usual-type endocervical adenocarcinoma and gastric adenocarcinoma of cervix.
    Magn Reson Imaging. 2024 Jun 5:S0730-725X(24)00165.
    PubMed         Abstract available


    Med Oncol

  57. HELMI N, Hamadi A, Al-Amer OM, Madkhali HA, et al
    Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins.
    Med Oncol. 2024;41:223.
    PubMed         Abstract available


    Medicine (Baltimore)

  58. ZHANG L, Yang X, Zhang Y, Wen Y, et al
    Cervical metastasis of breast cancer: A case report and literature review.
    Medicine (Baltimore). 2024;103:e39275.
    PubMed         Abstract available


    Methods

  59. LIANG Y, Guo Y, Zhai Y, Zhou J, et al
    Disease trend analysis platform accurately predicts the occurrence of cervical cancer under mixed diseases.
    Methods. 2024 Aug 5:S1046-2023(24)00180-4. doi: 10.1016/j.ymeth.2024.
    PubMed         Abstract available


    Natl Med J India

  60. PANKAJ S, Rani J, Kumari P, Abhilashi K, et al
    Prevalence, risk factors and genotype distribution of human papillomavirus infection among women with and without invasive cervical cancer: Findings from a hospital-based study in Bihar, India.
    Natl Med J India. 2024;37:13-17.
    PubMed         Abstract available


    Nurs Womens Health

  61. GALE A
    Increasing Referral Acceptance for Women's Health Services Among Hispanic Women.
    Nurs Womens Health. 2024;28:296-302.
    PubMed         Abstract available


    Oncol Lett

  62. SONG R, Cong L, Ni G, Chen M, et al
    [Retracted] MicroRNA?195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.
    Oncol Lett. 2024;28:464.
    PubMed         Abstract available


    Phys Eng Sci Med

  63. BROWN R, Holloway L, Lau A, Lim K, et al
    Potential anatomical triggers for plan adaptation of cervical cancer external beam radiotherapy.
    Phys Eng Sci Med. 2024 Aug 8. doi: 10.1007/s13246-024-01473.
    PubMed         Abstract available


    PLoS One

  64. NAZRUL N, de Fouw M, Beltman JJ, de Zeeuw J, et al
    Understanding cervical cancer awareness in hard-to-reach areas of Bangladesh: A cross-sectional study involving women and household decisionmakers.
    PLoS One. 2024;19:e0304396.
    PubMed         Abstract available

  65. LORDELO MV, Oliveira CZ, Aguirre Buexm L, Vieira Reis RM, et al
    Randomized experimental population-based study to evaluate the acceptance and completion of and preferences for cervical cancer screening.
    PLoS One. 2024;19:e0306130.
    PubMed         Abstract available


    S Afr Fam Pract (2004)

  66. NDUBUISI CC, Maphasha O, Okeke SO
    Knowledge and awareness of cervical cancer and human papillomavirus vaccination among female university students.
    S Afr Fam Pract (2004). 2024;66:e1-e8.
    PubMed         Abstract available


    Sci Rep

  67. BEYENE DA, Ayele SG, Wubneh HD, Tsige AW, et al
    Male support for cervical cancer screening in Debre Berhan City Ethiopia a community based cross sectional survey.
    Sci Rep. 2024;14:18302.
    PubMed         Abstract available

  68. KALSOOM A, Altaf A, Sarwar M, Maqbool T, et al
    GC-MS analysis, molecular docking, and apoptotic-based cytotoxic effect of Caladium lindenii Madison extracts toward the HeLa cervical cancer cell line.
    Sci Rep. 2024;14:18438.
    PubMed         Abstract available


    Small

  69. CHEN L, Ming H, Li B, Yang C, et al
    Tumor-Specific Nano-Herb Delivery System with High L-Arginine Loading for Synergistic Chemo and Gas Therapy against Cervical Cancer.
    Small. 2024 Aug 5:e2403869. doi: 10.1002/smll.202403869.
    PubMed         Abstract available


    Strahlenther Onkol

  70. ELMALI A, Guler OC, Demirhan B, Yavuz M, et al
    Long-term analysis of hematological parameters as predictors of recurrence patterns and treatment outcomes in cervical cancer patients undergoing definitive chemoradiotherapy.
    Strahlenther Onkol. 2024 Aug 5. doi: 10.1007/s00066-024-02278.
    PubMed         Abstract available


    Talanta

  71. FAKTOR J, Henek T, Hernychova L, Singh A, et al
    Metaproteomic analysis from cervical biopsies and cytologies identifies proteinaceous biomarkers representing both human and microbial species.
    Talanta. 2024;278:126460.
    PubMed         Abstract available


    Value Health

  72. LEI J, Zhang J, You C, Liu M, et al
    First-Line Treatment with Atezolizumab plus Bevacizumab and Chemotherapy for US Patients with Metastatic, Persistent, or Recurrent Cervical Cancer: A Cost-Effectiveness Analysis.
    Value Health. 2024 Aug 1:S1098-3015(24)02796-7. doi: 10.1016/j.jval.2024.
    PubMed         Abstract available


    Virol J

  73. HU JP, Wang JL, Li Y, Feng Y, et al
    Prevalence and genotype distribution of human papillomavirus infection among 66000 women from 2014 to 2023 in the plateau region of Southwest China.
    Virol J. 2024;21:176.
    PubMed         Abstract available


    Zhongguo Zhong Yao Za Zhi

  74. PANG XY, Zhou R, Song RT, Li N, et al
    [Effect of total saponins from Panacis Majoris Rhizoma on proliferation, apoptosis and autophagy of human cervical carcinoma HeLa cells].
    Zhongguo Zhong Yao Za Zhi. 2024;49:3848-3856.
    PubMed         Abstract available


    Zhonghua Bing Li Xue Za Zhi


  75. [Expert consensus on p16/Ki-67 dual staining in cervical cytology].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:783-788.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.